从出生到青春期末的阿迪波内克丁度与胰岛素抵抗的相关性
Yeran Lee1, Soren Harnois-Leblanc2, Sheryl L Rifas-Shiman2
1Stritch School of Medicine, Loyola University Chicago, Maywood, Illinois, USA.
Pediatric obesity
|April 24, 2025
概括
从童年中期开始较低的皮素水平与青春晚期更高的胰岛素抵抗有关,特别是在男性中. 这突出显示了脂肪菌素.
科学领域:
- 儿科内分泌学 儿科内分泌学
- 代谢健康 代谢健康
- 阿迪波基因研究研究
背景情况:
- 研究了从出生到青春期的阿迪波内克丁度.
- 在青春晚期检查了与胰岛素抵抗的关联.
- 利用Project Viva前性出生队列研究的数据.
研究的目的:
- 确定童年和青春期阿迪波涅克丁水平与后来的胰岛素耐药性之间的关系.
- 了解阿迪波涅克丁轨迹如何影响代谢健康发展.
- 确定这些关联中的潜在的性别特异性差异.
主要方法:
- 采用多变量线性回归模型.
- 在多个时间点 (出生,童年,青春期) 评估阿迪波涅丁z分数.
- 在青春晚期使用胰岛素耐药 (HOMA-IR) 恒温模式测量胰岛素耐药性.
主要成果:
- 观察到童年中期,早期和晚年青春期的阿迪波内克丁z分数和晚年青春期的HOMA-IR之间的反向关联.
- 在对体质指数 (BMI) z-score进行调整后,这些关联被减弱.
- 与女性相比,男性的关联性更明显.
结论:
- 从童年中期开始,较低的阿迪波涅丁度与青春晚期胰岛素耐药性增加有关.
- 阿迪波涅丁与胰岛素抵抗之间的联系在男性中更为明显.
- 研究结果表明,阿迪波内克丁在儿童和青少年时期的胰岛素耐药性发展中起着作用.
关键词:
亚迪波基因 (Adipokine) 是一种可靠的药物.没有任何的Adiponectin.阿迪波内克与勒的比率是什么青春期 青春期 青春期胰岛素耐药性是一种胰岛素耐药性.儿科 儿科 儿科一个潜在的队列.更多相关视频
08:34Mechanism of Regulation of Adipocyte Numbers in Adult Organisms Through Differentiation and Apoptosis Homeostasis
Published on: June 3, 2016
14.9K
10:28Isolation, Expansion, and Adipogenic Induction of CD34+CD31+ Endothelial Cells from Human Omental and Subcutaneous Adipose Tissue
Published on: July 17, 2018
11.7K
相关概念视频
Insulin: The Receptor and Signaling Pathways
1.0K
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
1.0K
Obesity
307
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
307
Insulin: Dosing Regimen and Adverse Effects
125
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
125
Diabetes: Symptoms, Diagnosis, and Complications
475
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
475
Diabetes Mellitus: Type 2 and Gestational
2.1K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.1K
Signs of Puberty
148
Puberty is a critical phase, typically beginning between the ages of 8 and 13 in girls and 9 and 14 in boys, though timing can vary based on genetics, environmental factors, and overall health. This period is characterized by the development of secondary sexual characteristics and the attainment of reproductive potential. Endocrine changes underpin puberty, with hormonal surges of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) instigated by Gonadotropin-Releasing Hormone (GnRH)...
148
